Ibuprofen

Description

This product is available in a package containing 40 units. Each unit is designed for precise dosing and administration. The formulation is intended for professional use, ensuring consistency and reliability in therapeutic applications.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with headache, toothache, backache, menstrual cramps, the common cold, muscular aches, and minor pain of arthritis. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be administered according to the following guidelines to ensure safety and efficacy.

For adults and children aged 12 years and older, the recommended dosage is 1 capsule every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 capsule, a maximum of 2 capsules may be taken. It is imperative that the total dosage does not exceed 6 capsules within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Healthcare professionals should emphasize the importance of using the smallest effective dose and adhering strictly to the prescribed dosage to avoid potential adverse effects.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to any other pain reliever or fever reducer. Additionally, administration is contraindicated immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen has the potential to induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of such reactions may include hives, facial swelling, asthma (manifested as wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance without delay.

Healthcare professionals should advise patients to cease ibuprofen administration and contact their physician if they experience any signs of gastrointestinal bleeding. These signs may include feeling faint, vomiting blood, passing bloody or black stools, or experiencing persistent stomach pain that does not improve.

Additionally, patients should be instructed to seek medical attention if they exhibit symptoms suggestive of cardiovascular issues or stroke. These symptoms include chest pain, difficulty breathing, slurred speech, unilateral weakness, leg swelling, worsening pain that persists beyond 10 days, fever that intensifies or lasts more than 3 days, redness or swelling in the affected area, or the emergence of any new symptoms.

Regular monitoring and prompt reporting of these symptoms are essential for the safe use of ibuprofen.

Side Effects

Patients may experience a range of adverse reactions while using ibuprofen, which can vary in seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters.

In clinical settings, patients are advised to discontinue use and seek medical attention if they exhibit signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve.

Additionally, symptoms indicative of heart problems or stroke warrant immediate medical consultation. These symptoms include chest pain, difficulty breathing, slurred speech, weakness localized to one side of the body, leg swelling, worsening pain lasting more than 10 days, fever that intensifies or persists beyond three days, redness or swelling in the painful area, and the emergence of any new symptoms.

Monitoring for these adverse reactions is essential to ensure patient safety and effective management of any potential complications.

Drug Interactions

Ibuprofen may interact with several medications, leading to significant clinical effects.

Pharmacodynamic Interactions:

• Aspirin: The concurrent use of ibuprofen may diminish the cardioprotective effects of aspirin when used for the prevention of heart attack or stroke. It is advisable to separate the administration of these medications to optimize the therapeutic benefit of aspirin.

• Other NSAIDs: The use of ibuprofen alongside other nonsteroidal anti-inflammatory drugs (NSAIDs), including prescription and nonprescription options such as aspirin and naproxen, increases the risk of gastrointestinal complications, particularly stomach bleeding. Caution is warranted when combining these agents.

• Anticoagulants and Steroids: The risk of stomach bleeding is further elevated in patients taking blood thinners (anticoagulants) or steroid medications. Close monitoring for gastrointestinal symptoms is recommended in these cases.

Pharmacokinetic Interactions:

• Diuretics: Patients on diuretics should consult a healthcare provider prior to initiating ibuprofen therapy. The combination may necessitate dosage adjustments or increased monitoring to prevent potential adverse effects.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 capsule every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 capsule, 2 capsules may be administered. The maximum dosage should not exceed 6 capsules in a 24-hour period unless directed by a healthcare provider.

Geriatric Use

Elderly patients, particularly those aged 60 years and older, may have an increased risk of severe stomach bleeding. Healthcare providers should exercise caution when prescribing this medication to geriatric patients, considering the potential for heightened adverse effects.

It is advisable to closely monitor elderly patients for any signs of gastrointestinal bleeding and to evaluate the necessity of dosage adjustments based on individual patient factors. Careful assessment of the risk-benefit ratio is essential when treating this population to ensure optimal safety and efficacy.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication, especially if they are in the later stages of pregnancy or breastfeeding. It is particularly important to avoid the use of ibuprofen during the last trimester unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should weigh the potential benefits against the risks when considering the use of this medication in pregnant patients.

Lactation

Lactating mothers are advised to consult a health professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen during the last three months of pregnancy unless specifically directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of ibuprofen in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication in lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the available data. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the lack of information necessitates careful evaluation of individual patient needs and potential risks associated with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant in monitoring for symptoms that may arise from an overdose. While specific symptoms are not detailed in the provided information, it is essential to be aware that they can vary based on the substance involved and the individual patient’s response.

Management of an overdose typically involves supportive care and symptomatic treatment. Healthcare providers are advised to follow established protocols for overdose management, which may include the administration of activated charcoal, intravenous fluids, or other interventions as deemed necessary based on the clinical presentation.

In summary, timely medical intervention and appropriate management strategies are critical in addressing overdose situations effectively.

Nonclinical Toxicology

It is especially important not to use ibuprofen during the last three months of pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects or additional nonclinical toxicology details are available in the provided data. Furthermore, there are no specific findings related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of the product. Reports have included gastrointestinal bleeding, renal impairment, and elevations in liver enzymes. Additionally, serious cardiovascular events, such as myocardial infarction and stroke, have been documented.

Severe allergic reactions, including anaphylaxis and angioedema, have also been reported. Skin reactions, notably Stevens-Johnson syndrome and toxic epidermal necrolysis, have been observed in some cases. Furthermore, postmarketing surveillance has indicated an increased risk of gastrointestinal complications in patients with a history of peptic ulcer disease.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this product if they have ever experienced an allergic reaction to any other pain reliever or fever reducer. It is crucial to instruct patients to avoid using the medication right before or after heart surgery.

Patients should be made aware of the signs of potential stomach bleeding and instructed to stop use and consult a doctor if they experience any of the following symptoms: feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. Additionally, patients should be advised to seek medical attention if they exhibit symptoms indicative of heart problems or stroke, such as chest pain, trouble breathing, slurred speech, weakness in one part or side of the body, leg swelling, worsening pain lasting more than 10 days, fever worsening or lasting more than 3 days, redness or swelling in the painful area, or any new symptoms.

When using this product, patients should be counseled to take it with food or milk if they experience stomach upset. Healthcare providers should recommend that patients consult a doctor before use if the warning regarding stomach bleeding applies to them. It is also important to advise patients to seek medical advice if they have experienced problems or serious side effects from taking pain relievers or fever reducers in the past.

Patients with a history of stomach problems, such as heartburn, should be encouraged to discuss this with their healthcare provider before using the medication. Additionally, those with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should be advised to consult a doctor prior to use. Patients taking diuretics should also be encouraged to seek medical advice before using this product.

Furthermore, healthcare providers should inform patients to consult a doctor or pharmacist before use if they are under a doctor’s care for any serious condition or if they are taking aspirin for heart attack or stroke, as ibuprofen may diminish the benefits of aspirin. Lastly, patients should be advised to discuss any other medications they are taking with their healthcare provider or pharmacist before using this product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a controlled room temperature of 20-25°C (68-77°F). Care must be taken to avoid exposure to excessive heat, specifically temperatures exceeding 40°C (104°F), to maintain product integrity. Proper container requirements should be adhered to, ensuring that the product is kept in suitable conditions to prevent degradation. Special handling needs should be observed to ensure the product remains within the recommended temperature range throughout its storage and handling processes.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid ibuprofen during the last three months of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Ibuprofen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)